Heart Attack (Myocardial Infarction) Clinical Trials

1. Background 1.1. Antiplatelet therapy after acute myocardial infarction Dual antiplatelet therapy with aspirin, combined with a P2Y12 receptor inhibitor, is a cornerstone of therapy for acute myocardial infarction (AMI). Treatment with clopidogrel in addition to aspirin resulted in a 20% reduction in major adverse cardiovascular events (MACE) when compared ...

The THEMIS clinical research study is evaluating a study drug to see if it may help prevent heart attack and stroke in people with type 2 diabetes.

Announcing a new research study of nutritional supplements Specifically, the study will examine whether certain supplements can reduce readmission rates in adults >65 years of age who are hospitalized for the following diagnoses: Heart attack Heart failure COPD Pneumonia

People with these conditions have a higher risk of heart attack or stroke in the future. Because we know who is at a greater risk, we want to take early steps to try to prevent a cardiovascular emergency. The Aleprevent clinical research study will look at whether an investigational medication ...

Have you been told that you have or that you are at risk for developing Heart Disease? If you are 45 years of age or older and have high triglyceride levels, you may be eligible to participate in a clinical research study evaluating the safety and effectiveness of an investigational ...

If you have Type 2 Diabetes and are concerned about the health of your heart, this study could be for you. Those with diabetes know they are at a higher risk of having heart attacks, strokes, and other cardiovascular complications. If you've already had a stroke or a heart attack ...

A clinical research study is underway for those who have been diagnosed with Type 2 diabetes, have high Triglycerides, low HDL cholesterol “good cholesterol”, and are at risk for future cardiovascular events. The main goal of this study is to learn, if a potential new medication can help prevent heart ...

Patients who wish to enroll in a research study should discuss the possibilities with their urologist. The TUCC Clinical Research Department staff remains in constant communication with patients throughout their enrollment in clinical trials. These patients receive all study related medication and procedures at no cost. Participation is voluntary and ...

The researchers are doing the study to see if semaglutide may reduce the risk of having cardiovascular events in patients with overweight or obesity and with prior cardiovascular disease. The participant will either get semaglutide (active medicine) or placebo ("dummy" medicine). Which treatment the participants get is decided by chance. ...

The treatment options this study will compare are: (1) Hybrid Coronary Revascularization [HCR] (a combination of surgery and catheter procedures to open up clogged heart arteries) and (2) Percutaneous Coronary Intervention [PCI] (catheter procedures alone to open up clogged heart arteries). There are no new or "experimental" procedures being tested ...